SOST and rheumatoid arthritis: Moreover, in RA patients, higher levels of another Wnt inhibitors, sclerostin, correlates with disease activity scores and inflammation markers; in addition, in RA mice models anti-sclerostin antibodies arrested the bone damage progression and in combination with anti-TNF led to regression of cortical bone erosions.